Down Syndrome (Trisomy 21)
Chromosomal Aneuploidy Syndrome
Primary risk age: Apparent at birth (Screened prenatally; lifelong condition)
- Urgency
- Moderate
- Typical age
- Apparent at birth (Screened prenatally; lifelong condition)
- Body system
- Genetic & Chromosomal
Typical course: This is a lifelong chromosomal genetic condition requiring continuous multidisciplinary support.
Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13
1. Summary & Pathophysiology
Chromosomal Aneuploidy Syndrome
Pathophysiology (Development Path)
The presence of an extra copy of chromosome 21 results in the overexpression of genes on this chromosome. This alters embryonic development, leading to characteristic craniofacial features, cognitive impairment, congenital heart defects, and immune system changes.
Primary Causes & Etiology
Meiotic nondisjunction during gametogenesis leading to three copies of chromosome 21 (95% of cases); translocation or mosaicism in the remainder.
2. Symptom Continuum
- Early Onset Signs
Moderate to severe hypotonia ("floppiness") at birth, a flat facial profile, upslanting palpebral fissures (eye slits), small ears, and a single transverse palmar crease (Simian crease).
- Progressive Phase
Delayed motor milestones (sitting, walking), mild to moderate intellectual disability, short stature, and speech delays.
- Severe Indicators
Congenital heart disease (such as an Atrioventricular Septal Defect), duodenal atresia (blockage of the intestine), hearing loss, thyroid dysfunction, and an increased risk of childhood leukemia.
3. Clinical Verification
Confirmed by karyotype analysis showing three copies of chromosome 21. Prenatal screening via cell-free DNA (cfDNA) or ultrasound markers (increased nuchal translucency).
4. Care & Elements Plan
Primary Care Treatment Plan
Multidisciplinary supportive management. Screen for associated medical conditions: echocardiogram at birth, annual thyroid function tests, regular hearing and vision exams, and early intervention therapies (physical, occupational, and speech therapies).
Home Support Elements
Support developmental milestones through structured play, physical exercises, and speech stimulation. Maintain regular pediatric checkups.
Generic Active Ingredients (No Brands)
- None. This is a primary chromosomal genetic condition
- medications are used only to manage secondary complications (e.g., levothyroxine for hypothyroidism).
Lists active elements only. Never administer self-designed therapies.
5. Doctor Critical Lines
Critical Thresholds: When to See a Doctor
Any newborn suspected of Down syndrome based on physical features requires a karyotype. Seek urgent care for rapid breathing, poor feeding, or blue coloring, suggesting a heart defect.
6. Vaccine & Prevention
Routine Prophylaxis (Prevention)
No prevention exists; incidence increases with maternal age. Genetic counseling is recommended.
Immunization Context
Children with Down syndrome should receive all routine immunizations, as they have an increased susceptibility to respiratory infections.
7. Timelines & Outlook
Active Timeline
This is a lifelong chromosomal genetic condition requiring continuous multidisciplinary support.
Expected Prognosis
Good. With modern medical care and early intervention, life expectancy has increased to 60 years or older.
Potential Untreated Complications
Congenital heart disease, thyroid dysfunction, celiac disease, sleep apnea, atlantoaxial instability, and early-onset Alzheimer's disease.
